No Data
No Data
No Data
No Data
No Data
Canaccord Genuity Adjusts Price Target on Quanterix to $25 From $32, Maintains Buy Rating
Quanterix (QTRX) has an average outperform rating and a price target range of $20 to $35, according to analysts polled by Capital IQ. Price: 16.05, Change: +0.49, Percent Change: +3.15
MT NewswiresApr 29 23:13
Quanterix Is Maintained at Buy by Canaccord Genuity
Quanterix Is Maintained at Buy by Canaccord Genuity
Dow JonesApr 29 22:49
Canadian Investment Banking Group: Maintaining the Quanterix (QTRX.US) rating, adjusted from a buy rating to a buy rating, and the target price was adjusted from $32.00 to $25.00.
Canadian Investment Banking Group: Maintaining the Quanterix (QTRX.US) rating, adjusted from a buy rating to a buy rating, and the target price was adjusted from $32.00 to $25.00.
Zhitong FinanceApr 29 22:40
Canaccord Genuity Maintains Buy on Quanterix, Lowers Price Target to $25
Canaccord Genuity analyst Kyle Mikson maintains Quanterix (NASDAQ:QTRX) with a Buy and lowers the price target from $32 to $25.
BenzingaApr 29 22:39
Quanterix To Report First Quarter 2024 Financial Results
PDF Version BILLERICA, Mass.--(BUSINESS WIRE)--Apr. 29, 2024-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today annou
QuanterixApr 29 12:00
Analysts' Top Healthcare Picks: Quanterix (QTRX), Intuitive Surgical (ISRG)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Quanterix (QTRX), Intuitive Surgical (ISRG) and Arvinas Holding Company (ARVN) with bullish sentiments.
TipRanksApr 16 14:40
No Data
No Data